300 related articles for article (PubMed ID: 16188937)
1. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
2. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
[TBL] [Abstract][Full Text] [Related]
3. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
Neumann J; Koch N
J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
[TBL] [Abstract][Full Text] [Related]
4. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
5. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
6. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
Rich T; Lawler SE; Lord JM; Blancheteau VM; Charron DJ; Mooney NA
J Immunol; 1997 Oct; 159(8):3792-8. PubMed ID: 9378966
[TBL] [Abstract][Full Text] [Related]
7. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
Swier K; Miller J
J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
9. ER egress of invariant chain isoform p35 requires direct binding to MHCII molecules and is inhibited by the NleA virulence factor of enterohaemorrhagic Escherichia coli.
Cloutier M; Gauthier C; Fortin JS; Genève L; Kim K; Gruenheid S; Kim J; Thibodeau J
Hum Immunol; 2015 Apr; 76(4):292-6. PubMed ID: 25731712
[TBL] [Abstract][Full Text] [Related]
10. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
[TBL] [Abstract][Full Text] [Related]
11. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.
Kuwana T; Peterson PA; Karlsson L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1056-61. PubMed ID: 9448284
[TBL] [Abstract][Full Text] [Related]
12. Control of glycosylation of MHC class II-associated invariant chain by translocon-associated RAMP4.
Schröder K; Martoglio B; Hofmann M; Hölscher C; Hartmann E; Prehn S; Rapoport TA; Dobberstein B
EMBO J; 1999 Sep; 18(17):4804-15. PubMed ID: 10469658
[TBL] [Abstract][Full Text] [Related]
13. Intracellular transport of class II MHC molecules directed by invariant chain.
Lotteau V; Teyton L; Peleraux A; Nilsson T; Karlsson L; Schmid SL; Quaranta V; Peterson PA
Nature; 1990 Dec; 348(6302):600-5. PubMed ID: 2250716
[TBL] [Abstract][Full Text] [Related]
14. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74.
Genève L; Ménard C; Labrecque N; Thibodeau J
Int Immunol; 2012 Oct; 24(10):645-60. PubMed ID: 22966065
[TBL] [Abstract][Full Text] [Related]
15. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
16. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.
Kang SJ; Cresswell P
EMBO J; 2002 Apr; 21(7):1650-60. PubMed ID: 11927549
[TBL] [Abstract][Full Text] [Related]
17. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
Teyton L; O'Sullivan D; Dickson PW; Lotteau V; Sette A; Fink P; Peterson PA
Nature; 1990 Nov; 348(6296):39-44. PubMed ID: 2234057
[TBL] [Abstract][Full Text] [Related]
18. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
19. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.
Roche PA; Marks MS; Cresswell P
Nature; 1991 Dec; 354(6352):392-4. PubMed ID: 1956401
[TBL] [Abstract][Full Text] [Related]
20. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
